Trials / Sponsors / Suzhou Yabao Pharmaceutical R&D Co., Ltd.

Suzhou Yabao Pharmaceutical R&D Co., Ltd.

Industry · 12 registered clinical trials.

Status	Trial	Phase	Started
Suspended	SY007 in Patients With Acute Ischemic Stroke Acute Ischemic Stroke	Phase 1	2023-07-01
Unknown	The Efficacy and Safety of Different Doses of SY-009 in Patients With Type 2 Diabetes Mellitus Type 2 Diabetes	Phase 2	2022-07-01
Unknown	SY-005 （Recombinant Human Annexin A5）in Patients With Sepsis Sepsis	Phase 2	2022-01-02
Completed	A Food-drug Interaction Study of SY-004 in Healthy Subjects Type 2 Diabetes	Phase 1	2021-08-31
Completed	A Drug Interaction Study of SY-004 Capsules in Healthy Subjects Type 2 Diabetes	Phase 1	2021-07-06
Completed	Multiple Ascending Doses of SY-008 in Type 2 Diabetes Mellitus Type 2 Diabetes Mellitus	Phase 1	2020-06-15
Completed	Multiple Ascending Doses of SY-009 in Type 2 Diabetes Mellitus Type 2 Diabetes Mellitus	Phase 1	2020-05-01
Completed	The Efficacy and Safety of Different Doses of SY-004 in Patients With Type 2 Diabetes Mellitus Type 2 Diabetes Mellitus	Phase 2	2019-12-10
Completed	Single-dose/Multiple-doses Incremental Intravenous Injection of SY-005 （Recombinant Human Annexin A5）in Health Sepsis	Phase 1	2019-04-26
Completed	Single-dose Incremental Intravenous Injection of SY-007 in Healthy Subjects Cerebral Apoplexy	Phase 1	2019-03-05
Completed	Single Ascending Oral Doses of SY-009 in Healthy Subjects Diabetes	Phase 1	2019-03-01
Completed	Single Ascending Oral Doses of SY-008 in Healthy Subjects Diabetes	Phase 1	2018-08-02